Nitrendipine and Enalapril combination therapy in hypertension:: A clinical trial of 4 x 4 factorial design

被引：0
|
作者：
Torres, F
Terán, M
Delgadillo, J
Horas, M
Ríos, J
Calvo, O
Jané, F
Roca-Cusachs, A
机构：
[1] Hosp Sant Pau, Serv Clin Pharmacol, Barcelona, Spain
[2] Autonomous Univ Barcelona, Epidemiol & Biostat Lab, Barcelona, Spain
[3] Vita Invest SA, Barcelona, Spain
[4] Hosp Sant Path, Hypertens Unit, Barcelona, Spain
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
10.1097/00004872-200006001-00307
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] Tasosartan and Hydroclorothiazide as Combination Therapy in the Treatment of Severe Essential Hypertension: Comparison with Enalapril
    M. Viigimaa
    K. Allikmets
    T. Parik
    J. Skards
    A. Franken
    G. Häass
    Cardiovascular Drugs and Therapy, 2000, 14 : 447 - 449
  • [22] Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial
    Rakugi, Hiromi
    Ogihara, Toshio
    Umemoto, Seiji
    Matsuzaki, Masunori
    Matsuoka, Hiroaki
    Shimada, Kazuyuki
    Higaki, Jitsuo
    Ito, Sadayoshi
    Kamiya, Akira
    Suzuki, Hiromichi
    Ohashi, Yasuo
    Shimamoto, Kazuaki
    Saruta, Takao
    HYPERTENSION RESEARCH, 2013, 36 (11) : 947 - 958
  • [23] Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial
    Hiromi Rakugi
    Toshio Ogihara
    Seiji Umemoto
    Masunori Matsuzaki
    Hiroaki Matsuoka
    Kazuyuki Shimada
    Jitsuo Higaki
    Sadayoshi Ito
    Akira Kamiya
    Hiromichi Suzuki
    Yasuo Ohashi
    Kazuaki Shimamoto
    Takao Saruta
    Hypertension Research, 2013, 36 : 947 - 958
  • [24] Design of the Optimal Trial of Combination Therapy
    Cappola, Anne R.
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [25] COMBINATION THERAPY OF HYPERTENSION WITH BETA-ADRENOCEPTOR BLOCKERS AND THE CALCIUM-CHANNEL ANTAGONIST NITRENDIPINE
    MACCARTHY, EP
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 : S76 - S79
  • [26] Combination of TOPROL-XL and hydrochlorothiazide: Results of a factorial clinical trial
    Papademetriou, V
    Hainer, JW
    Sugg, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 91A - 91A
  • [27] TREATMENT OF ESSENTIAL-HYPERTENSION IN ASIANS - ENALAPRIL AS MONOTHERAPY VERSUS COMBINATION THERAPY WITH HYDROCHLOROTHIAZIDE
    JONES, DW
    SANDS, CD
    PHARMACOTHERAPY, 1991, 11 (02): : 127 - 130
  • [28] INHIBITION OF RENAL-INSUFFICIENCY PROGRESSION IN GLOMERULAR-DISEASES BY DIETARY-PROTEIN RESTRICTION AND COMBINATION THERAPY WITH ENALAPRIL AND NITRENDIPINE
    KULT, J
    BUNDSCHU, HD
    ROMEN, W
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1995, 24 (05) : 256 - 258
  • [29] CLINICAL-EXPERIENCE WITH LABETALOL AND ENALAPRIL IN COMBINATION IN PATIENTS WITH SEVERE ESSENTIAL AND RENOVASCULAR HYPERTENSION
    WHITE, WB
    AYDELOTTE, ME
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (03): : 187 - 191
  • [30] An application of a factorial design to a phase I clinical trial.
    Carr, A
    Montague, TH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P64 - P64
12345